Club Members

More than 1,500+ Social Members have joined our virtual and in-person events. Club Membership is reserved for Life Science Dealmakers including senior executive Investors, Advisors, CEOs, Strategic Partners, Non-Profits, Government Agencies, and others who bring value to our core mission. Each prospective Club Member must complete an interview prior to acceptance.

Attending

Sector

Stages

Khatija Ali

Khatija Ali

CEO

Attending JPM 2024

Jeffrey D. Allen

Jeffrey Allen

Attending JPM 2024

Pharmaceutical, Device, Service, Tool

Commercial

Caley Anderson

Caley Anderson

Director of Business Development

Attending JPM 2024

Anna Argo

Anna Argo

Director of Business Development

Attending JPM 2024

Device, Biologic, Tool

Primary human hepatocytes, liver research, allogeneic cell therapy, hepatocyte transplant, liver assist device, rare disease, toxicology and metabolic safety, drug discovery tool

Series A

Scott Arnold

Scott Arnold

Co-Founder

Attending JPM 2024

Pharmaceutical

AI / ML, Drug Development

Seed

Priya Baraniak

Priya R. Baraniak, Ph.D

Chief Business Officer

Attending JPM 2024

Service, Tool

Tissue Sourcing. Cell Isolation and Cryopreservation. GMP Manufacturing. Clinical Trial Support. Immunotherapy. Cell Therapy. Cord Blood. Leukopaks.

Series A

Austin Barrett

Austin Barrett

Vice Chairman

Attending JPM 2024

Nizar Batada

Nizar Batada

CEO

Attending JPM 2024

Biologic

tissue targeting, inflammation, inflammatory bowel disease, gamma delta T cells

Seed

Amy Baxter

Amy Baxter

Founder & CEO

Attending JPM 2024

Device

Low back pain; neuromodulation; post-surgery pain; opioid-sparing; drug-free; profitable; NIH Funded

Commercial

Todd Bertsch

Todd Bertsch

Venture Partner

Rob Blatt

Rob Blatt

CEO and Co-Founder

Attending JPM 2024

John Bonham-Carter

John Bonham-Carter

Board Advisor

Attending JPM 2024

Biologic, Tool

Cell Therapy Cryopreservation

Series A

Marcel Botha

Marcel Botha

CEO

Attending JPM 2024

Device, Digital, Service, Diagnostic, Tool, Other

Connected Health

Seed

James Bowman

James Bowman

CEO

Attending JPM 2024

Bill Breitenbach

Bill Breitenbach

CEO

Attending JPM 2024

Ross Bundy

Ross Bundy

CEO

Attending JPM 2024

Digital, Service, Other

Series A

Tom Burke

Tom Burke

CEO & Board Chairman

Attending JPM 2024

Diagnostic

Sepsis -- Early, Non-Invasively Detection to Save Lives

Series A

Sudip Chakrabortty (Deep)

Deep Chakrabortty

CEO

Attending JPM 2024

Preet Chaudhary

Preet Chaudhary

Founder

Attending JPM 2024

Pharmaceutical

Cell Therapy, Next generation TCR like CAR technology for solid tumors, blood cancers and autoimmune indications

Seed

Mehdi Chelbi

Mehdi Chelbi

CEO

Pharmaceutical

Oncology First-in-class

Series A

Dominic Clarke

Dominic Clarke

CSO

Pharmaceutical, Service, Biologic, Other

Marketing, Cell Therapy, Gene Therapy

Seed

Alex Condon

Alex Condon

COO

Attending JPM 2024

Device, Digital, Service, Other

Medical Device Cloud Data Management Platform

Commercial

Rajiv Datar

Rajiv Datar

President & CEO

Attending JPM 2024

Service, Tool

gene therapy products, AAV, LV, mRNA, pDNA, continuous chromatography purification, continuous bioprocessing

Series B

George Eastwood

Board Chairman

Attending JPM 2024

Phil Ebner

Phil Ebner

Executive Director, Life Sciences

Attending JPM 2024

Kayte Edson

Kayte Edson

Founder

Attending JPM 2024

Kristin Eilenberg

Kristin Eilenberg

Vice President - Life Sciences and Healthcare

Attending JPM 2024

Christiaan Engstrom

Christiaan Engstrom

CEO

Attending JPM 2024

Biologic, Tool

Cell Therapy Cryopreservation

Series A

John Erbey

John Erbey

CEO

Attending JPM 2024

Device

Kidney AKI CKD

Series A

Karl-Rudolf Erlemann

Karl-Rudolf Erlemann

President & Owner

Attending JPM 2024

Thomas Forest Farb-Horch

Thomas Forest Farb-Horch

CEO

Attending JPM 2024

Tool

Automated live cell imaging and analytics

Commercial

John Forrest

John Forrest

CEO, Co-Founder & Executive Chairman

Attending JPM 2024

Roger Frechette

Roger Frechette

CBO

Attending JPM 2024

Pharmaceutical, Biologic

microbial products, live biotherapeutic product, microbiome, dermatology, women's health

Series B

Robert Fremeau

Robert Fremeau

Founder & CSO

Attending JPM 2024

Pharmaceutical, Digital, Tool

brain organoid; iPSC; neurodegeneration; neuropsychiatry; neurology; Parkinson's disease; schizophrenia; Alzheimers disease

Seed

Yuki Furuta

Yuki Furuta

VP, Business development and Venture Investment

Attending JPM 2024

Diagnostic, Tool

Commercial

Rahul Garg

Rahul Garg

Chief Strategy Officer

Britton Garrett

Britton Garrett

CEO

Kirt Gill

Kirt Gill

CEO

Attending JPM 2024

Device

Stroke, Neurostimulation, Wearable, Noninvasive

Seed

Mike Goodrich

Mike Goodrich

Principal

Attending JPM 2024

Pharmaceutical, Device, Digital, Service, Diagnostic, Other

Commercial